Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zoulim

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Gastroenterologie Clinique Et Biologique|November 25, 2010
[Analogs combination therapy in chronic hepatitis B: when and how?]A Kahloun, M Bourlière, F Zoulim
Drugs & Aging|December 12, 2001
Current management strategies for hepatitis B in the elderlyP Merle, C Trépo, F Zoulim
Gastroenterologie Clinique Et Biologique|February 1, 1995
[Experimental models for the study of hepadnaviruses and antiviral strategies]F Zoulim, C Seeger, C Trépo
Journal of Virology|March 1, 1994
Woodchuck hepatitis virus X protein is required for viral infection in vivoF Zoulim, J Saputelli, C Seeger
Current Opinion in Infectious Diseases|October 13, 2006
Viral hepatitisC Trépo, F Zoulim, P Pradat
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Clinical implications of interactions between hepatitis B virus and mononuclear leukocytes]F Zoulim, J P Lamelin, C Trepo
Hepato-Gastroenterology|February 1, 1991
Favorable outcome in fulminating hepatitis associated with native anti-DNA antibodiesJ C Normand, F Zoulim, L Descos
International Journal of Clinical & Laboratory Research|January 1, 1995
Lymphotropism of hepatitis B and C viruses: an update and a newcomerJ P Lamelin, F Zoulim, C Trépo
Journal of Viral Hepatitis|November 21, 2007
Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?F Zoulim, M Buti, A S Lok
Current Pharmaceutical Design|May 2, 2000
Design and evaluation of hepatitis B virus inhibitorsO Hantz, J L Kraus, F Zoulim
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Gastroenterologie Clinique Et Biologique|November 25, 2010
[Analogs combination therapy in chronic hepatitis B: when and how?]A Kahloun, M Bourlière, F Zoulim
Drugs & Aging|December 12, 2001
Current management strategies for hepatitis B in the elderlyP Merle, C Trépo, F Zoulim
Gastroenterologie Clinique Et Biologique|February 1, 1995
[Experimental models for the study of hepadnaviruses and antiviral strategies]F Zoulim, C Seeger, C Trépo
Journal of Virology|March 1, 1994
Woodchuck hepatitis virus X protein is required for viral infection in vivoF Zoulim, J Saputelli, C Seeger
Current Opinion in Infectious Diseases|October 13, 2006
Viral hepatitisC Trépo, F Zoulim, P Pradat
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Clinical implications of interactions between hepatitis B virus and mononuclear leukocytes]F Zoulim, J P Lamelin, C Trepo
Hepato-Gastroenterology|February 1, 1991
Favorable outcome in fulminating hepatitis associated with native anti-DNA antibodiesJ C Normand, F Zoulim, L Descos
International Journal of Clinical & Laboratory Research|January 1, 1995
Lymphotropism of hepatitis B and C viruses: an update and a newcomerJ P Lamelin, F Zoulim, C Trépo
Journal of Viral Hepatitis|November 21, 2007
Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?F Zoulim, M Buti, A S Lok
Current Pharmaceutical Design|May 2, 2000
Design and evaluation of hepatitis B virus inhibitorsO Hantz, J L Kraus, F Zoulim
Pageof 13